Two Boca Health members walking together by the water
Weight Loss

WEIGHT LOSS PERSONALIZED WEIGHT LOSS PERSONALIZED

Personalized treatment options designed to support sustainable weight loss, healthier habits, and long-term results.

Semaglutide

Compounded Injections

Semaglutide

Tirzepatide

Compounded Injections

Tirzepatide

Same Price, Even as Your Dose Changes

Benefits:

  • Reduced Hunger & Cravings
  • Feel Fuller, Longer
  • Meaningful Weight Loss
  • More Energy for Everyday Life

Online GLP-1 weight loss care at Boca Health: the short answer

Boca Health offers compounded semaglutide and compounded tirzepatide through an online telehealth visit in all 50 states, subject to provider licensure and state rules (current state availability). An independent provider licensed in the patient's state reviews each health intake and decides whether treatment is appropriate. Completing an intake does not guarantee a prescription.

Compounded medications are not FDA-approved and are not the same as, or equivalent to, any FDA-approved product. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. Independent providers who practice through Boca Health prescribe compounded semaglutide and compounded tirzepatide only when they determine a patient-specific clinical need, and a state-licensed 503A compounding pharmacy prepares the medication.

Both are typically given as once-weekly injections, on a schedule the provider sets. Semaglutide acts on the GLP-1 receptor; tirzepatide acts on both the GIP and GLP-1 receptors. Results vary, and treatment is used alongside nutrition and activity changes. GLP-1 medications can cause side effects, some serious; read the safety information before starting.

joinboca.com is LegitScript certified, which is not FDA approval or an endorsement of any medication.

Can women in perimenopause or menopause get GLP-1 care online at Boca Health?

Boca Health providers can evaluate women in perimenopause or menopause for GLP-1 care online, and prescribe only where they determine treatment is appropriate. Boca Health offers online care for women, including weight management during perimenopause and menopause. GLP-1 medications are not approved specifically for menopause-related weight changes. The same online intake and independent provider review apply, and the provider considers the patient's full health history, including any hormone therapy, before deciding whether to prescribe.

Common follow-up questions

Treatment Options

TWO PATHS. ONE GOAL. TWO PATHS. ONE GOAL.

BOCA offers two compounded injectable treatment options for weight management. Your medical history, goals, previous treatment, and provider review help determine which option may be appropriate for you.

Semaglutide

One Powerful Pathway

Semaglutide

Semaglutide targets the GLP-1 receptor, helping regulate appetite, increase feelings of fullness, and support weight loss. GLP-1 medications mimic a naturally occurring hormone involved in appetite regulation.

Tirzepatide

Two Hormones. Dual Action.

Tirzepatide

Tirzepatide targets both GIP and GLP-1 receptors, two pathways involved in appetite and metabolic regulation.

WHY WEIGHT CHANGES

YOUR BODY CHANGED THE RULES YOUR BODY CHANGED THE RULES

What worked before may not work the same way today. Changes in hormones, metabolism, appetite, and body composition can make losing weight harder, even when you’re doing the right things.

Weight management isn’t simply about willpower. Modern treatment can help address the biological signals that influence hunger, fullness, and how much you eat.

Hunger

Help turn down the signals telling you it’s time to eat.

Cravings

Spend less time thinking about food throughout the day.

Fullness

Feel satisfied sooner and stay fuller longer.

Progress

Make it easier to build habits that support your long-term goals.

A Boca Health member eating lunch on a waterfront terrace

HOW GLP-1s WORK

LESS HUNGER. LESS FOOD NOISE. MORE CONTROL. LESS HUNGER. LESS FOOD NOISE. MORE CONTROL.

GLP-1 medications mimic hormones your body naturally produces after eating. They act on areas involved in appetite and fullness, helping you feel satisfied sooner and stay fuller longer. Some also slow digestion, which can further support feelings of fullness.

The result?

Eating less can start to feel less like a constant battle.

Feel Fuller, Faster

Appetite signals help your brain recognize when you’ve had enough.

Stay Satisfied Longer

Slower digestion can help extend feelings of fullness between meals.

Quiet the Cravings

Reduced appetite can make food feel less demanding of your attention.

Two women in a bright kitchen looking at a phone together

BETTER HEALTH BEGINS WITH BOCA BETTER HEALTH BEGINS WITH BOCA

Expert care, personalized treatment, and seamless access, all designed to help you look, feel, and live your best.

Get Started Now

Before choosing GLP-1 treatment

Are compounded GLP-1 medications FDA-approved?

No. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. FDA recommends using them only when a patient’s medical needs cannot be met by an FDA-approved drug. Read FDA’s guidance on unapproved GLP-1 drugs.

Who decides whether treatment is appropriate?

An independent provider licensed in your state reviews your health information and determines whether to prescribe. Completing an intake does not guarantee a prescription. See how provider review works and current state availability.

What will treatment cost?

Check the selected plan’s price, payment schedule, and renewal terms before purchase. Compare the total commitment as well as the monthly equivalent. View Boca’s current pricing.

Compare Boca with other online GLP-1 providers. This comparison, published by Boca Health, summarizes what each provider states publicly, with sources and the date checked.

Medical information and sources · Editorial standards

Important Safety Information

Compounded semaglutide and tirzepatide are GLP-1 medications that can cause side effects, including nausea, vomiting, diarrhea, constipation, and other gastrointestinal symptoms; serious risks may include pancreatitis and gallbladder problems. GLP-1 medications carry a boxed warning for the risk of thyroid C-cell tumors and are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Not for use during pregnancy. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. Talk to a licensed provider about whether treatment is right for you. Individual results vary.

Compounded medications are prepared by state-licensed compounding pharmacies under applicable USP standards. They are not FDA-approved and have not been reviewed by the FDA for safety or effectiveness. Prescription treatment requires evaluation by a licensed provider, who determines whether any treatment is appropriate for you. Treatment is not appropriate for everyone. Individual results vary.

Read the full medical disclaimer and safety information before starting treatment.